Produktname:tetrasodium;5-[[[(1S)-1-(4-bromophenyl)ethyl]amino]-phosphonatomethyl]quinoxaline-2,3-diolate
IUPAC Name:tetrasodium 5-({[(1S)-1-(4-bromophenyl)ethyl]amino}(phosphonato)methyl)quinoxaline-2,3-bis(olate)
- CAS:2102348-87-6
- Molekulare Formel:C17H13BrN3Na4O5P
- Reinheit:95%+
- Katalognummer:CM674053
- Molekulargewicht:542.14
Packungseinheit |
Verfügbarer Vorrat |
Preis($) |
Menge |
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:2102348-87-6
- Molekulare Formel:C17H13BrN3Na4O5P
- Schmelzpunkt:-
- SMILES-Code:[Na+].[Na+].[Na+].[Na+].C[C@H](NC(C1=CC=CC2=NC([O-])=C([O-])N=C12)P([O-])([O-])=O)C1=CC=C(Br)C=C1
- Dichte:
- Katalognummer:CM674053
- Molekulargewicht:542.14
- Siedepunkt:
- Mdl-Nr.:MFCD08705420
- Lagerung:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.